Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02311257 · ClinicalTrials.gov registry record

Survey on Supplement Use in Mitochondrial Disease

A clinical trial, sponsored by University of South Florida.

Completed
Registry status
162
Enrollment target

NCT02311257: Completed study, sponsored by University of South Florida.

NCT02311257 is a clinical trial that has completed, run by University of South Florida. The registered enrollment target is 162 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02311257 has completed, sponsored by University of South Florida.

COMPLETED
Registry status
162 participants
Enrollment target

Study Summary

The purpose of this study is to learn about the use of nutritional supplements in patients with mitochondrial disease.

Primary Outcome

This cross-sectional survey will assess nutritional supplements used by patients with mitochondrial disease.

Trial Details

FieldValue
Enrollment Target 162 participants
Start Date 2014-09
Est. Completion 2015-03
University of South Florida

252 total trials

What the finished NCT02311257 record still lists

NCT02311257 is an observational study that tracks outcomes without assigning an intervention. The registered 162 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT02311257 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02311257 about?

NCT02311257 is a clinical study titled "Survey on Supplement Use in Mitochondrial Disease". The purpose of this study is to learn about the use of nutritional supplements in patients with mitochondrial disease.

What is the current status of trial NCT02311257?

This trial is currently completed. The enrollment target is 162 participants. The study started on 2014-09. Estimated completion is 2015-03.

Who is sponsoring clinical trial NCT02311257?

This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02347111 · 162 participants · Phase 4

    Pharmacogenetic Study of Antiarrhythmic Drugs for Atrial Fibrillation

  • NCT02610426 · 162 participants

    Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Congestive Heart Failure Receiving Therapy for Breast Cancer

  • NCT05040711 · 162 participants · NA

    mHealth Mindfulness With Patients With Serious Illness and Their Caregivers

  • NCT05514717 · 162 participants · Phase 1

    A Study of XMT-2056 in Advanced/Recurrent Solid Tumors That Express HER2

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02311257, the US trial registry maintained by the National Library of Medicine. NCT02311257 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.